Albuterol Inhaler Dosage and Usage for Bronchospasm in Asthma and COPD
The recommended dosage for albuterol inhaler in adults is 2 inhalations (180-200 μg) every 4-6 hours as needed for bronchospasm in asthma or COPD, with more frequent administration (every 20 minutes for 1 hour) during acute exacerbations. 1, 2
Standard Dosing Recommendations
Adults and Adolescents (≥12 years)
- Mild symptoms: 2 inhalations (180-200 μg) of albuterol via hand-held inhaler every 4-6 hours as needed 1
- Moderate symptoms: 2-4 inhalations (180-400 μg) every 4 hours as needed 1
- Acute exacerbations: 4-8 inhalations every 20 minutes for up to 4 hours, then every 1-4 hours as needed 3, 1
Children (2-11 years)
- Standard dosing: 2 inhalations (180-200 μg) every 4-6 hours as needed 2
- Acute exacerbations: 4-8 puffs every 20 minutes for 3 doses, then every 1-4 hours as needed 3
Nebulizer Dosing (When Inhaler Use Is Not Possible)
Adults and Children ≥15 kg
- 2.5 mg (one 3 mL vial of 0.083% solution) administered 3-4 times daily 2
- For acute severe asthma/COPD: 5 mg nebulized, repeated every 4-6 hours if improved 3
Children <15 kg
Administration Technique
Proper MDI technique:
- Shake inhaler well before use
- Exhale completely
- Place mouthpiece in mouth with lips sealed around it (or 1-2 inches from open mouth)
- Begin slow, deep inhalation and activate inhaler
- Continue inhaling slowly and deeply
- Hold breath for 10 seconds
- Wait 30-60 seconds between inhalations
With spacer/holding chamber (preferred method):
- Attach inhaler to spacer
- Shake well
- Exhale completely
- Place mouthpiece in mouth with lips sealed
- Activate one puff into spacer
- Inhale slowly and deeply
- Hold breath for 10 seconds
- Wait 30-60 seconds between inhalations
Treatment Algorithm for Acute Exacerbations
Mild-to-Moderate Exacerbation
- Start with 4-8 puffs of albuterol via MDI with spacer every 20 minutes for up to 1 hour 1, 4
- Assess response after 1 hour:
- Add oral corticosteroids if not improving after initial treatment
Severe Exacerbation
- Administer oxygen to maintain saturation 88-92% in COPD or >94% in asthma 1
- Give nebulized albuterol 5 mg (or 2.5 mg if using MDI with spacer) 3, 1
- Consider adding ipratropium bromide 500 μg to albuterol if no improvement 3
- Administer systemic corticosteroids
- Consider hospitalization if no improvement after repeated treatments
Special Considerations
- Elderly patients: Monitor for cardiovascular side effects; albuterol may precipitate angina in susceptible patients 3
- Patients with glaucoma: Use mouthpiece rather than face mask with nebulized therapy to avoid eye exposure to medication 1
- Paradoxical bronchospasm: Though rare, discontinue albuterol and seek immediate medical attention if worsening shortness of breath occurs after administration 5
- Overuse warning: Increasing need for albuterol (using >2 canisters/month or >10-12 puffs/day) indicates poor asthma control and need for reassessment of maintenance therapy 3, 2
Monitoring Parameters
- Relief of symptoms
- Improvement in peak flow measurements
- Side effects: tremor, tachycardia, palpitations, headache
- Frequency of use (increasing use suggests need for controller medication adjustment)
Hand-held inhalers are preferred for most patients, with nebulizers reserved for those who cannot use inhalers properly or during severe exacerbations requiring higher medication doses 1.